TTR is used in clinical practice as a marker in several conditions, such as predicting outcome for critically ill patients [10], in Alzheimer's disease [11,12], amyloidosis [13], inflammation and malnutrition [14]. This evidence concerns the gene TTR and nutritional deficiency disease.